Risk factors of hemorrhagic transformation after intravenous thrombolysis with rt-PA in acute cerebral infarction

被引:71
|
作者
Wang, R. [1 ,2 ]
Zeng, J. [1 ]
Wang, F. [3 ,4 ]
Zhuang, X. [1 ]
Chen, X. [1 ]
Miao, J. [1 ]
机构
[1] Xiamen Univ, Zhongshan Hosp, Dept Neurol, Xiamen 361004, Fujian, Peoples R China
[2] Weinan Cent Hosp, Dept Neurol, Weinan 714000, Peoples R China
[3] Xiamen Univ, Dept Elect Sci, Fujian Prov Key Lab Plasma & Magnet Resonance, Xiamen 361005, Fujian, Peoples R China
[4] Jimei Univ, Sch Comp Engn, Xiamen 361021, Fujian, Peoples R China
关键词
ACUTE ISCHEMIC-STROKE; INTRACEREBRAL HEMORRHAGE; COAGULATION;
D O I
10.1093/qjmed/hcy292
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Intravenous thrombolysis is considered to be the standard reperfusion therapy for acute ischemic stroke, but its application is limited by high risk of hemorrhagic transformation (HT) after thrombolysis. Aim: This study aimed to identify risk factors of HT after intravenous thrombolysis. Methods: Patients with acute ischemic stroke receiving rt-PA thrombolysis from February 2013 to January 2018 were retrospectively reviewed. They were divided into HT group and non-HT group based on cranial computed tomography. Data of all patients were collected and analysed by univariate analysis and stepwise logistic regression analysis. Results: A total of 403 patients were enrolled and their age ranged from 13 to 86 years, with an average age of 67.01 +/- 31.88 years. 136 (33.7%) patients were females. The average time from disease onset to thrombolysis was 52.05 +/- 20.12 min, and 46 patients (11.4%) had HT after thrombolysis. We found significant differences in activated partial thromboplastin time, fibrinogen value, platelet value and smoking before thrombolysis between HT and non-HT group (P<0.05). Conclusion: Smoking, prolongation of activated partial thromboplastin time, low fibrinogen levels and low platelet counts are associated with the risk of HT and could help the selection of thrombolytic patients to avoid HT.
引用
收藏
页码:323 / 326
页数:4
相关论文
共 50 条
  • [21] Effect of intravenous thrombolysis in acute ischemic stroke patients with cerebral microbleeds and analysis of risk factors for hemorrhagic transformation
    Lei, Y-S
    Li, H.
    Lei, J-Y
    Li, S-X
    Li, D-F
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (03) : 779 - 786
  • [22] Stroke MRI in patients undergoing intravenous thrombolysis with rt-PA
    Schellinger, P
    Jansen, O
    Helland, S
    Steiner, T
    Sartor, K
    Hacke, W
    STROKE, 2000, 31 (11) : 2888 - 2888
  • [23] Gender Differences in the Use of Intravenous rt-PA Thrombolysis Treatment for Acute Ischemic Stroke
    Huang, Ying-Ting
    Yu, Hui-Fen
    Lin, Hsiao Chu
    Lin, Ya-Ju
    Po, Helen L.
    Chuo, Chao-Liang
    CEREBROVASCULAR DISEASES, 2014, 38 : 30 - 30
  • [24] Factors predicting the outcome of intravenous thrombolysis in stroke patients before rt-PA administration
    Mehrpour, Masoud
    Afrakhte, Motahare
    Shojaei, Seyedeh Fahimeh
    Sohrabi, Ahmad
    Ashayeri, Rezan
    Esmaeili, Sara
    Bahadori, Maryam
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2019, 10 (04) : 424 - 430
  • [25] RETRACTION: Clinical Effect of Butylphthalide Combined with Rt-PA Intravenous Thrombolysis in the Treatment of Acute Cerebral Infarction (Retraction of Vol 2022, art no 9215685, 2022)
    Zhou, X.
    Yang, J.
    Liu, L.
    Zhu, Y.
    APPLIED BIONICS AND BIOMECHANICS, 2023, 2023
  • [26] Safety of Full Dose Intravenous rt-PA Followed by Intra-Arterial Therapy for Acute Cerebral Infarction
    Nogueira, Raul G.
    Masrur, Shihab
    Batista, Leonardo M.
    Hakimelahi, Reza
    Yoo, Albert J.
    Schwamm, Lee H.
    NEUROLOGY, 2010, 74 (09) : A194 - A195
  • [27] Risk of Symptomatic Intracerebral Hemorrhage after Thrombolysis with rt-PA: The SEDAN Score
    Bruening, Toralf
    Al-Khaled, Mohamed
    CNS NEUROSCIENCE & THERAPEUTICS, 2015, 21 (03) : 296 - 297
  • [28] Clinical Evaluation of Cerebral Microbleeds (MBs) after Intravenous rt-PA Therapy
    Fujiwara, Shunya
    CEREBROVASCULAR DISEASES, 2018, 46 : 29 - 29
  • [29] THE RISK OF HEMORRHAGIC COMPLICATIONS WITH RT-PA IS NOT INFLUENCED BY THROMBUS
    BECKER, R
    BALL, S
    CORRAO, J
    KLASSEN, V
    BAKER, S
    ANSELL, J
    ARTERIOSCLEROSIS, 1990, 10 (05): : A929 - A929
  • [30] Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator (rt-PA) in Acute Lower Limb Ischaemia
    Flis, V.
    Kobilica, N.
    Bergauer, A.
    Mrdza, B.
    Milotic, F.
    Stirn, B.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2011, 39 (03) : 1107 - 1112